These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements throughout the United Kingdom for the licensing, manufacture, marketing, wholesale dealing and the sale and supply of medicines for human use. They also amend the Medicines Act 1968 (“the 1968 Act”).